SPOP and prostate cancer: Interestingly, most SPOP mutations identified in human prostate cancers, such as Y87C, F102C, W131G, and F133L, are located in the MATH domain of SPOP, which presumably impairs its ability to bind to and recruit substrates into the Cullin 3SPOP complex (Figure 5A).